These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26211928)

  • 41. Urinary bladder urothelial carcinoma with concurrent plasmacytoid and micropapillary differentiations: A report of two cases with an emphasis on serum carbohydrate antigen 19-9.
    Makise N; Morikawa T; Takeshima Y; Fujimura T; Homma Y; Fukayama M
    Pathol Int; 2015 Sep; 65(9):495-500. PubMed ID: 26044127
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Basaloid squamous cell carcinoma of the sinonasal tract.
    Wieneke JA; Thompson LD; Wenig BM
    Cancer; 1999 Feb; 85(4):841-54. PubMed ID: 10091761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Histopathology of urinary bladder carcinoma: less common variants.
    Damjanov I; Golubović M
    Srp Arh Celok Lek; 2011; 139(9-10):693-9. PubMed ID: 22070010
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Large cell undifferentiated carcinoma of the urinary bladder.
    Lopez-Beltran A; Cheng L; Comperat E; Rouprêt M; Blanca A; Menendez CL; Montironi R
    Pathology; 2010 Jun; 42(4):364-8. PubMed ID: 20438410
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Flat urothelial carcinoma in situ of the bladder with glandular differentiation.
    Lopez-Beltran A; Jimenez RE; Montironi R; Patriarca C; Blanca A; Menendez CL; Algaba F; Cheng L
    Hum Pathol; 2011 Nov; 42(11):1653-9. PubMed ID: 21531007
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Utility of uroplakin II expression as a marker of urothelial carcinoma.
    Tian W; Guner G; Miyamoto H; Cimino-Mathews A; Gonzalez-Roibon N; Argani P; Li X; Sharma R; Subhawong AP; Rezaei K; Bivalacqua TJ; Epstein JI; Bishop JA; Netto GJ
    Hum Pathol; 2015 Jan; 46(1):58-64. PubMed ID: 25449628
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of cytokeratin 7, 20, 14 in urothelial carcinoma and squamous cell carcinoma of the Egyprian urinary bladder cancer.
    Hammam O; Wishahiz M; Khalil H; El Ganzouri H; Badawy M; Elkhquly A; Elesaily K
    J Egypt Soc Parasitol; 2014 Dec; 44(3):733-40. PubMed ID: 25643514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Large nested variant of urothelial carcinoma: 23 cases mimicking von Brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma.
    Cox R; Epstein JI
    Am J Surg Pathol; 2011 Sep; 35(9):1337-42. PubMed ID: 21836490
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases.
    Jones TD; Kernek KM; Yang XJ; Lopez-Beltran A; MacLennan GT; Eble JN; Lin H; Pan CX; Tretiakova M; Baldridge LA; Cheng L
    Hum Pathol; 2005 Jul; 36(7):718-23. PubMed ID: 16084939
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistochemical profile of high-grade urothelial bladder carcinoma and prostate adenocarcinoma.
    Mhawech P; Uchida T; Pelte MF
    Hum Pathol; 2002 Nov; 33(11):1136-40. PubMed ID: 12454820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases.
    Compérat E; Roupret M; Yaxley J; Reynolds J; Varinot J; Ouzaïd I; Cussenot O; Samaratunga H
    Pathology; 2010 Dec; 42(7):650-4. PubMed ID: 21080874
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyclin A1 expression predicts progression in pT1 urothelial carcinoma of bladder: a tissue microarray study of 149 patients treated by transurethral resection.
    Munari E; Chaux A; Maldonado L; Compérat E; Varinot J; Bivalacqua TJ; Hoque MO; Netto GJ
    Histopathology; 2015 Jan; 66(2):262-9. PubMed ID: 25039670
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pulmonary giant cell carcinoma: pathological entity or morphological phenotype?
    Attanoos RL; Papagiannis A; Suttinont P; Goddard H; Papotti M; Gibbs AR
    Histopathology; 1998 Mar; 32(3):225-31. PubMed ID: 9568507
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasmacytoid urothelial carcinoma (UC) are luminal tumors with similar CD8+ Tcell density and PD-L1 protein expression on immune cells as compared to conventional UC.
    Kossaï M; Radulescu C; Adam J; Dziegielewski A; Signolle N; Sibony M; Lebret T; Allory Y; Rouanne M
    Urol Oncol; 2022 Jan; 40(1):12.e1-12.e11. PubMed ID: 34429252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasmacytoid urothelial carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of a case series.
    Raspollini MR; Sardi I; Giunti L; Di Lollo S; Baroni G; Stomaci N; Menghetti I; Franchi A
    Hum Pathol; 2011 Aug; 42(8):1149-58. PubMed ID: 21334719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Invasive urothelial carcinoma exhibiting basal cell immunohistochemical markers: A variant of urothelial carcinoma associated with aggressive features.
    Mai KT; Truong LD; Ball CG; Williams P; Flood TA; Belanger EC
    Pathol Res Pract; 2015 Aug; 211(8):610-8. PubMed ID: 26100813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pleomorphic giant cell carcinoma of the prostate: clinicopathologic analysis and oncological outcomes.
    Bilé-Silva A; Lopez-Beltran A; Rasteiro H; Vau N; Blanca A; Gomez E; Gaspar F; Cheng L
    Virchows Arch; 2023 Mar; 482(3):493-505. PubMed ID: 36600115
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases.
    Fritsche HM; Burger M; Denzinger S; Legal W; Goebell PJ; Hartmann A
    J Urol; 2008 Nov; 180(5):1923-7. PubMed ID: 18801525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Both cancerous miR-21 and stromal miR-21 in urothelial carcinoma are related to tumour progression.
    Ohno R; Uozaki H; Kikuchi Y; Kumagai A; Aso T; Watanabe M; Watabe S; Muto S; Yamaguchi R
    Histopathology; 2016 Dec; 69(6):993-999. PubMed ID: 27383043
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma.
    Patschan O; Sjödahl G; Chebil G; Lövgren K; Lauss M; Gudjonsson S; Kollberg P; Eriksson P; Aine M; Månsson W; Fernö M; Liedberg F; Höglund M
    Eur Urol; 2015 Nov; 68(5):824-32; discussion 835-6. PubMed ID: 25770486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.